Anaptysbio (ANAB) Treasury Shares (2016 - 2026)
Anaptysbio (ANAB) posted Treasury Shares of $1.4 million for Q1 2026, up 191.72% on a QoQ basis from $478000.0 in Q4 2025, and down 8.06% year-over-year from $1.5 million in Q1 2025.
Anaptysbio (ANAB) Treasury Shares (2016 - 2026) Analysis & Trends
Anaptysbio's Treasury Shares history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- Quarterly Treasury Shares fell 8.06% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 8.06% YoY) and the FY2025 annual result came in at $478000.0, down 61.06% from the prior year.
- Treasury Shares was $1.4 million for Q1 2026 at Anaptysbio, up from $478000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.5 million in Q1 2025 and bottomed at $478000.0 in Q4 2025.
- A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares soared 54.17% — and 2024, when it sank 64.17%.
- Anaptysbio's Treasury Shares stood at $1.0 million in 2022, then soared by 44.0% to $1.5 million in 2023, then decreased by 17.14% to $1.2 million in 2024, then sank by 61.06% to $478000.0 in 2025, then soared by 191.72% to $1.4 million in 2026.
- Business Quant data shows ANAB's Treasury Shares at $1.4 million in Q1 2026, $478000.0 in Q4 2025, and $498000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 34.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 5.14 Mn |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | 1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.39 Mn |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 478,000.00 |
| Dec 31, 2025 | 478,000.00 |
| Sep 30, 2025 | 498,000.00 |
| Sep 30, 2025 | 498,000.00 |
| Jun 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 511,000.00 |
| Sep 30, 2024 | 511,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |